Amneal Pharmaceuticals, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2024
Total Assets: $3.50B
Liabilities Breakdown FY2024
Total Liabilities: $3.61B
Asset Breakdown
Total Assets: $3.50B
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $110.6M | 3.2% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $612.5M | 17.5% |
| Property, Plant & Equipment | $424.9M | 12.1% |
| Goodwill | $597.4M | 17.1% |
| Intangible Assets | $732.4M | 20.9% |
| Other Assets | $1.02B | 29.2% |
Liabilities Breakdown
Total Liabilities: $3.61B
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $0 | 0.0% |
| Long-Term Debt | $2.16B | 59.9% |
| Other Liabilities | $1.45B | 40.1% |